1 / 3

Oncolytic Virus Therapy Market Growth Opportunities

Oncolytic Virus Therapy Market report which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market.

John687
Télécharger la présentation

Oncolytic Virus Therapy Market Growth Opportunities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oncolytic Virus Therapy Market Growth Opportunities, Trends and Share Forecast 2035 Oncolytic Virus Therapy Market report which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market. Oncolytic Virus Therapy MarketStatistics – •USD 84.45 Million revenue in 2022 •The market size is projected to record a valuation of over USD 1,147.89 Million by 2035 •The membrane filtration industry is slated to observe 27.07% growth rate through 2023-2035 Get Your Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-2988 In the year 2020, deaths caused to cancer was estimated to be around 10 Million, according to the statistics by the World Health Organization. With the rising cases of cancer globally, there is an increasing need amongst the healthcare specialists for advanced cancer detection and treatment procedures, which is one of the major factors anticipated to drive the growth of the global oncolytic virus therapy market. The increasing healthcare expenditure and the rapid surge in the approvals of immune-oncology drugs by the medical fraternities, such as the United States Food and Drug Administration (FDA), are some of the additional factors projected to drive the market growth. The global oncolytic virus therapy market is estimated to grow with a CAGR of 27.29% over the forecast period, i.e., 2021 – 2028. The market is anticipated to garner a revenue of USD 1062.7 Million by the end of 2028, up from a revenue of USD 160.4 Million in the year 2019. Based on therapy type, the market is segmented into HSV-based oncolytic virus therapy, adenovirus-based oncolytic virus therapy, reovirus, poxviruses, Newcastle disease virus (NDV), and others. Amongst these

  2. segments, in the year 2019, the adenovirus-based oncolytic virus therapy segment held the highest market share of 30.2%, and is further expected to hold significant market share in the coming years. According to recent study by Research Nester, the Oncolytic Virus Therapy Market size is anticipated to surpass USD 1,147.89 Million by 2035 and is projected to expand at CAGR of over 27.07% from 2023 to 2023. Major players include in the global Oncolytic Virus Therapy Market: •Amgen Inc. oCompany Overview oBusiness Strategy oKey Product Offerings oFinancial Performance oKey Performance Indicators oRisk Analysis oRecent Development oRegional Presence oSWOT Analysis •Shanghai Sunway Biotech Co., Ltd. •Oncolys BioPharma Inc. •TILT Biotherapeutics Ltd. •Oncorus, Inc. •Takara Bio Inc. •Vyriad •Transgene sa •Lokon Pharma AB •Pfizer Inc. •Rigvir Group •Shenzhen Sibiono GeneTech Co. Ltd. •Oncolytics Biotech Inc. •Daiichi Sankyo •Kissei Pharmaceutical Co., Ltd.

  3. •Boehringer Ingelheim Get Your Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-2988 On the basis of region, the global oncolytic virus therapy market is segmented into North America, Europe, Asia Pacific, and the Rest of World, out of which, the market in North America is projected to attain the largest market revenue of USD 509.4 Million by the end of 2028 and also grab the highest market share throughout the forecast period. Moreover, in the year 2019, the market in the region registered a revenue of USD 68.5 Million. However, the high cost of cancer drug development is one of the major factors anticipated to hamper the market growth. This report also provides the existing competitive scenario of some of the key players of the global oncolytic virus therapy market, which includes company profiling of Amgen Inc., Shanghai Sunway Biotech Co., Ltd., Oncolys BioPharma Inc., TILT Biotherapeutics Ltd., Oncorus, Inc., Takara Bio Inc., Vyriad, Transgene sa, Lokon Pharma AB, Pfizer Inc., and others. Buy a Copy of this Strategic Report to drive your Business Growth @ https://www.researchnester.com/reports/oncolytic-virus-therapy- market/2988 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties. Contact Us: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919

More Related